CLINICAL STUDY
Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass
outcome of diabetic patients in the AWESOME randomized trial and registry
Steven P. Sedlis, MD, FACC*,*,
Douglass A. Morrison, MD, FACC ,
Jeffrey D. Lorin, MD, FACC*,
Rick Esposito, MD*,
Gulshan Sethi, MD, FACC,
Jerome Sacks, PhD ,
William Henderson, PhD,
Frederick Grover, MD, FACC ,
K. B. Ramanathan, MD, FACC||,
Darryl Weiman, MD||,
Jorge Saucedo, MD¶,
Tamim Antakli, MD¶,
Venki Paramesh, MD,
Stuart Pett, MD**,
Sarah Vernon, MD, FACC**,
Vladimir Birjiniuk, MD,
Frederick Welt, MD,
Mitchell Krucoff, MD, FACC,
Walter Wolfe, MD, FACC,
John C. Lucke, MD,
Sundeep Mediratta, MD,
David Booth, MD, FACC||||,
Edward Murphy, MD, FACC¶¶,
Herbert Ward, MD, FACC***,
LaWayne Miller, MD,
Stefan Kiesz, MD, FACC,
Charles Barbiere, CCRN,
Dan Lewis, MD, FACC Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME)
* New York VA Medical Center, New York, New York, USA
Tucson VA Medical Center, Tucson, Arizona, USA
CSPCC Hines VA Hospital, Hines, Illinois, USA
Denver VA Medical Center, Denver, Colorado, USA
|| Memphis VA Medical Center, Memphis, Tennessee, USA
¶ Little Rock VA Medical Center, Little Rock, Arkansas, USA
** Albuquerque VA Medical Center, Albuquerque, New Mexico, USA
West Roxbury VA Medical Center, West Roxbury, Massachusetts, USA
Durham VA Medical Center, Durham, North Carolina, USA
Asheville VA Medical Center, Asheville, North Carolina, USA
|||| Lexington VA Medical Center, Lexington, Kentucky, USA
¶¶ Portland VA Medical Center, Portland, Oregon, USA
*** Minneapolis VA Medical Center, Minneapolis, Minnesota, USA
San Antonio VA Medical Center, San Antonio, Texas, USA
Kansas City VA Medical Center, Kansas City, Kansas, USA
Manuscript received February 27, 2002;
revised manuscript received April 30, 2002,
accepted May 31, 2002.
* Reprint requests and correspondence: Dr. Steven P. Sedlis, Section of Cardiology, 12W, VA Medical Center, 423 East 23rd Street, New York, New York 10010, USA.
steven.sedlis{at}med.va.gov
OBJECTIVES: This study compared survival after percutaneous coronary intervention (PCI) with survival after coronary artery bypass graft surgery (CABG) among diabetics in the Veterans Affairs AWESOME (Angina With Extremely Serious Operative Mortality Evaluation) study randomized trial and registry of high-risk patients.
BACKGROUND: Previous studies indicate that CABG may be superior to PCI for diabetics, but no comparisons have been made for diabetics at high risk for surgery.
METHODS: Over five years (1995 to 2000), 2,431 patients with medically refractory myocardial ischemia and at least one of five risk factors (prior CABG, myocardial infarction within seven days, left ventricular ejection fraction <0.35, age >70 years, or an intra-aortic balloon being required to stabilize) were identified. A total of 781 were acceptable for CABG and PCI, and 454 consented to be randomized. The 1,650 patients not acceptable for both CABG and PCI constitute the physician-directed registry, and the 327 who were acceptable but refused to be randomized constitute the patient-choice registry. Diabetes prevalence was 32% (144) among randomized patients, 27% (89) in the patient-choice registry, and 32% (525) in the physician-directed registry. The CABG and PCI survival rates were compared using Kaplan-Meier curves and log-rank tests.
RESULTS: The respective CABG and PCI 36-month survival rates for diabetic patients were 72% and 81% for randomized patients, 85% and 89% for patient-choice registry patients, and 73% and 71% for the physician-directed registry patients. None of the differences was statistically significant.
CONCLUSIONS: We conclude that PCI is a relatively safe alternative to CABG for diabetic patients with medically refractory unstable angina who are at high risk for CABG.
|
Abbreviations and Acronyms
| | AWESOME | | Angina With Extremely Serious Operative Mortality Evaluation | | CABG | | coronary artery bypass graft surgery | | CAD | | coronary artery disease | | LVEF | | left ventricular ejection fraction | | MI | | myocardial infarction | | PCI | | percutaneous coronary intervention | | TIMI | | Thrombolysis In Myocardial Infarction |
|
This article has been cited by other articles:
|
|
|
|
 
D.-W. Park, S.-C. Yun, S.-W. Lee, Y.-H. Kim, C. W. Lee, M.-K. Hong, J.-J. Kim, S. J. Choo, H. Song, C. H. Chung, et al.
Long-Term Mortality After Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for the Treatment of Multivessel Coronary Artery Disease
Circulation,
April 22, 2008;
117(16):
2079 - 2086.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Bravata, A. L. Gienger, K. M. McDonald, V. Sundaram, M. V. Perez, R. Varghese, J. R. Kapoor, R. Ardehali, D. K. Owens, and M. A. Hlatky
Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery
Ann Intern Med,
November 20, 2007;
147(10):
703 - 716.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, J.-P. Bassand, C. W. Hamm, D. Ardissino, E. Boersma, A. Budaj, F. Fernandez-Aviles, K. A.A. Fox, D. Hasdai, E. M. Ohman, et al.
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
Eur. Heart J.,
July 1, 2007;
28(13):
1598 - 1660.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J. Suppl.,
June 1, 2007;
9(suppl_C):
C3 - C74.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Berry, J.-C. Tardif, and M. G. Bourassa
Coronary Heart Disease in Patients With Diabetes: Part II: Recent Advances in Coronary Revascularization
J. Am. Coll. Cardiol.,
February 13, 2007;
49(6):
643 - 656.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J.,
January 1, 2007;
28(1):
88 - 136.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. B. Ramanathan, D. S. Weiman, J. Sacks, D. A. Morrison, S. Sedlis, G. Sethi, and W. G. Henderson
Percutaneous Intervention Versus Coronary Bypass Surgery for Patients Older Than 70 Years of Age With High-Risk Unstable Angina
Ann. Thorac. Surg.,
October 1, 2005;
80(4):
1340 - 1346.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Roffi
Early invasive strategy in the diabetic patient with non-ST-segment elevation acute coronary syndromes
Eur. Heart J. Suppl.,
October 1, 2005;
7(suppl_K):
K19 - K22.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Flaherty and C. J. Davidson
Diabetes and Coronary Revascularization
JAMA,
March 23, 2005;
293(12):
1501 - 1508.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G W Mikhail, F Airoldi, D Tavano, A Chieffo, R Rogacka, M Carlino, M Montorfano, G Sangiorgi, N Corvaja, I Michev, et al.
The use of drug eluting stents in single and multivessel disease: results from a single centre experience
Heart,
September 1, 2004;
90(9):
990 - 994.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Locker, R. Mohr, O. Lev-Ran, G. Uretzky, A. Frimerman, Y. Shaham, and I. Shapira
Comparison of bilateral thoracic artery grafting with percutaneous coronary interventions in diabetic patients
Ann. Thorac. Surg.,
August 1, 2004;
78(2):
471 - 475.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Brener, B. W. Lytle, I. P. Casserly, J. P. Schneider, E. J. Topol, and M. S. Lauer
Propensity Analysis of Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease and High-Risk Features
Circulation,
May 18, 2004;
109(19):
2290 - 2295.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Roffi and E. J. Topol
Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes
Eur. Heart J.,
February 1, 2004;
25(3):
190 - 198.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Rumsfeld, D. J. Magid, M. E. Plomondon, J. Sacks, W. Henderson, M. Hlatky, G. Sethi, D. A. Morrison, and Veterans Affairs Angina With Extremely Serious Ope
Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia
J. Am. Coll. Cardiol.,
May 21, 2003;
41(10):
1732 - 1738.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
